SWOG clinical trial number
SWOG-8842
Dihydroxyazacytidine in Malignant Mesothelioma, Phase II
Closed
Phase
Accrual
100%
Published
Abbreviated Title
Dihydroxyazacytidine in Malignant Mesothelioma, Phase II
Activated
12/15/1989
Closed
11/15/1992
Research committees
Sarcoma
Publication Information Expand/Collapse
1998
A phase II Southwest Oncology Group study of dihydroxyazacytidine for mesothelioma.